Structure

Physi-Chem Properties

Molecular Weight:  654.23
Volume:  645.03
LogP:  2.382
LogD:  1.825
LogS:  -3.472
# Rotatable Bonds:  15
TPSA:  212.67
# H-Bond Aceptor:  13
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.076
Synthetic Accessibility Score:  4.408
Fsp3:  0.353
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.082
MDCK Permeability:  8.526501915184781e-06
Pgp-inhibitor:  0.096
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.845
20% Bioavailability (F20%):  0.971
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.029
Plasma Protein Binding (PPB):  97.93009185791016%
Volume Distribution (VD):  0.362
Pgp-substrate:  1.8960869312286377%

ADMET: Metabolism

CYP1A2-inhibitor:  0.161
CYP1A2-substrate:  0.094
CYP2C19-inhibitor:  0.203
CYP2C19-substrate:  0.049
CYP2C9-inhibitor:  0.801
CYP2C9-substrate:  0.666
CYP2D6-inhibitor:  0.409
CYP2D6-substrate:  0.594
CYP3A4-inhibitor:  0.158
CYP3A4-substrate:  0.125

ADMET: Excretion

Clearance (CL):  12.422
Half-life (T1/2):  0.964

ADMET: Toxicity

hERG Blockers:  0.211
Human Hepatotoxicity (H-HT):  0.211
Drug-inuced Liver Injury (DILI):  0.045
AMES Toxicity:  0.768
Rat Oral Acute Toxicity:  0.088
Maximum Recommended Daily Dose:  0.92
Skin Sensitization:  0.97
Carcinogencity:  0.156
Eye Corrosion:  0.003
Eye Irritation:  0.422
Respiratory Toxicity:  0.074

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC131532

Natural Product ID:  NPC131532
Common Name*:   Oregonoyl B
IUPAC Name:   [(2S,3R,4S,5R)-2-[(3S)-1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptan-3-yl]oxy-4,5-dihydroxyoxan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  QEQBTRZSJZAYTN-KRKLTZBFSA-N
Standard InCHI:  InChI=1S/C34H38O13/c1-44-30-16-21(6-12-26(30)38)7-13-31(42)47-33-32(43)29(41)18-45-34(33)46-23(9-3-20-5-11-25(37)28(40)15-20)17-22(35)8-2-19-4-10-24(36)27(39)14-19/h4-7,10-16,23,29,32-34,36-41,43H,2-3,8-9,17-18H2,1H3/b13-7+/t23-,29+,32-,33+,34-/m0/s1
SMILES:  COc1cc(/C=C/C(=O)O[C@H]2[C@@H](OC[C@H]([C@@H]2O)O)O[C@H](CC(=O)CCc2ccc(c(c2)O)O)CCc2ccc(c(c2)O)O)ccc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL590725
PubChem CID:   44602674
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15361 Alnus japonica Species Betulaceae Eukaryota bark n.a. n.a. PMID[20045319]
NPO15361 Alnus japonica Species Betulaceae Eukaryota n.a. n.a. n.a. PMID[26341132]
NPO15361 Alnus japonica Species Betulaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15361 Alnus japonica Species Betulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15361 Alnus japonica Species Betulaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO15361 Alnus japonica Species Betulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT742 Organism Influenza A virus Influenza A virus EC50 > 350000.0 nM PMID[469342]
NPT27 Others Unspecified CC50 > 500000.0 nM PMID[469342]
NPT2 Others Unspecified Activity = 71.3 % PMID[469343]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC131532 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9524 High Similarity NPC28776
0.9524 High Similarity NPC473138
0.92 High Similarity NPC478242
0.9145 High Similarity NPC478268
0.9085 High Similarity NPC87403
0.906 High Similarity NPC476382
0.906 High Similarity NPC34587
0.906 High Similarity NPC252292
0.906 High Similarity NPC34927
0.906 High Similarity NPC100998
0.9038 High Similarity NPC469654
0.902 High Similarity NPC106818
0.9007 High Similarity NPC28651
0.9007 High Similarity NPC199311
0.9007 High Similarity NPC3460
0.9007 High Similarity NPC261122
0.9007 High Similarity NPC80732
0.9007 High Similarity NPC215095
0.9007 High Similarity NPC300262
0.9007 High Similarity NPC116229
0.9007 High Similarity NPC201148
0.9007 High Similarity NPC210611
0.9007 High Similarity NPC192763
0.8987 High Similarity NPC246024
0.8986 High Similarity NPC140502
0.8981 High Similarity NPC44507
0.8974 High Similarity NPC223335
0.8974 High Similarity NPC40920
0.8974 High Similarity NPC133984
0.8954 High Similarity NPC300329
0.8947 High Similarity NPC259347
0.8947 High Similarity NPC306890
0.8947 High Similarity NPC476398
0.8947 High Similarity NPC94871
0.8947 High Similarity NPC470933
0.8947 High Similarity NPC471062
0.8947 High Similarity NPC476386
0.8947 High Similarity NPC473427
0.894 High Similarity NPC232992
0.891 High Similarity NPC11411
0.891 High Similarity NPC471405
0.8896 High Similarity NPC88560
0.8896 High Similarity NPC172033
0.8896 High Similarity NPC175230
0.8889 High Similarity NPC257970
0.8889 High Similarity NPC470927
0.8889 High Similarity NPC188393
0.8889 High Similarity NPC470934
0.8889 High Similarity NPC259576
0.8889 High Similarity NPC221091
0.8854 High Similarity NPC226759
0.8846 High Similarity NPC10205
0.8839 High Similarity NPC299706
0.8839 High Similarity NPC61604
0.8839 High Similarity NPC157898
0.8839 High Similarity NPC115466
0.8839 High Similarity NPC245615
0.8831 High Similarity NPC7145
0.8831 High Similarity NPC143480
0.8831 High Similarity NPC125823
0.8831 High Similarity NPC85192
0.8824 High Similarity NPC111785
0.8808 High Similarity NPC262182
0.8808 High Similarity NPC287615
0.8808 High Similarity NPC216819
0.8808 High Similarity NPC83743
0.88 High Similarity NPC478239
0.8797 High Similarity NPC469384
0.8797 High Similarity NPC478269
0.8795 High Similarity NPC471030
0.879 High Similarity NPC478055
0.8782 High Similarity NPC327032
0.8782 High Similarity NPC191046
0.8782 High Similarity NPC194095
0.878 High Similarity NPC316539
0.878 High Similarity NPC472993
0.8774 High Similarity NPC289967
0.8774 High Similarity NPC472611
0.8774 High Similarity NPC472612
0.8773 High Similarity NPC204937
0.8773 High Similarity NPC149011
0.8766 High Similarity NPC476871
0.8765 High Similarity NPC128403
0.8758 High Similarity NPC1580
0.875 High Similarity NPC285108
0.875 High Similarity NPC33298
0.875 High Similarity NPC476865
0.8742 High Similarity NPC110063
0.8735 High Similarity NPC267549
0.8734 High Similarity NPC472860
0.8734 High Similarity NPC286919
0.8734 High Similarity NPC475663
0.8733 High Similarity NPC157816
0.8726 High Similarity NPC38699
0.872 High Similarity NPC47140
0.872 High Similarity NPC67134
0.8718 High Similarity NPC137813
0.8718 High Similarity NPC44730
0.8712 High Similarity NPC197708
0.8712 High Similarity NPC21956
0.8712 High Similarity NPC658
0.8707 High Similarity NPC103398
0.8707 High Similarity NPC180171
0.8707 High Similarity NPC158325
0.8701 High Similarity NPC106138
0.8696 High Similarity NPC227297
0.8696 High Similarity NPC121290
0.869 High Similarity NPC199172
0.869 High Similarity NPC35924
0.8688 High Similarity NPC149873
0.8688 High Similarity NPC7191
0.8688 High Similarity NPC478267
0.8684 High Similarity NPC143120
0.8684 High Similarity NPC274960
0.8684 High Similarity NPC473909
0.8684 High Similarity NPC476868
0.8684 High Similarity NPC476866
0.8684 High Similarity NPC476864
0.8684 High Similarity NPC476869
0.8679 High Similarity NPC179914
0.8675 High Similarity NPC79736
0.8675 High Similarity NPC67629
0.8671 High Similarity NPC470896
0.8671 High Similarity NPC473275
0.8671 High Similarity NPC163635
0.8667 High Similarity NPC476377
0.8667 High Similarity NPC134405
0.8667 High Similarity NPC47471
0.8667 High Similarity NPC476385
0.8667 High Similarity NPC186406
0.8662 High Similarity NPC469888
0.8658 High Similarity NPC197316
0.8658 High Similarity NPC81515
0.8658 High Similarity NPC472350
0.8658 High Similarity NPC89105
0.8658 High Similarity NPC64141
0.8658 High Similarity NPC68092
0.8658 High Similarity NPC476383
0.8654 High Similarity NPC36130
0.8654 High Similarity NPC134905
0.865 High Similarity NPC116745
0.865 High Similarity NPC229729
0.865 High Similarity NPC298847
0.8649 High Similarity NPC52277
0.8649 High Similarity NPC177035
0.8649 High Similarity NPC199459
0.8649 High Similarity NPC157554
0.8645 High Similarity NPC12006
0.8645 High Similarity NPC158635
0.8645 High Similarity NPC229882
0.8642 High Similarity NPC475738
0.8639 High Similarity NPC25946
0.8639 High Similarity NPC470720
0.8639 High Similarity NPC470717
0.8639 High Similarity NPC460984
0.8639 High Similarity NPC470713
0.8639 High Similarity NPC21359
0.8639 High Similarity NPC471110
0.8634 High Similarity NPC148273
0.8634 High Similarity NPC471873
0.8631 High Similarity NPC469371
0.8627 High Similarity NPC199928
0.8625 High Similarity NPC239966
0.8625 High Similarity NPC203020
0.8625 High Similarity NPC289346
0.8623 High Similarity NPC476619
0.8623 High Similarity NPC476618
0.8623 High Similarity NPC476621
0.8623 High Similarity NPC139571
0.8623 High Similarity NPC217520
0.8623 High Similarity NPC476620
0.8623 High Similarity NPC476622
0.8623 High Similarity NPC472387
0.8623 High Similarity NPC477895
0.8623 High Similarity NPC476623
0.8618 High Similarity NPC232228
0.8618 High Similarity NPC476867
0.8616 High Similarity NPC471878
0.8614 High Similarity NPC473630
0.8609 High Similarity NPC265648
0.8609 High Similarity NPC222433
0.8606 High Similarity NPC469777
0.8606 High Similarity NPC469772
0.8606 High Similarity NPC469773
0.8606 High Similarity NPC102851
0.8606 High Similarity NPC100925
0.8606 High Similarity NPC469775
0.8606 High Similarity NPC469778
0.8606 High Similarity NPC32723
0.8606 High Similarity NPC135334
0.8606 High Similarity NPC469776
0.8606 High Similarity NPC5786
0.8606 High Similarity NPC295941
0.8606 High Similarity NPC469774
0.86 High Similarity NPC473799
0.86 High Similarity NPC475530
0.8598 High Similarity NPC229687
0.8591 High Similarity NPC78363
0.8591 High Similarity NPC260425
0.859 High Similarity NPC243891

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC131532 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8658 High Similarity NPD7266 Discontinued
0.8545 High Similarity NPD7074 Phase 3
0.8485 Intermediate Similarity NPD7054 Approved
0.8434 Intermediate Similarity NPD7472 Approved
0.8333 Intermediate Similarity NPD7685 Pre-registration
0.8323 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD7228 Approved
0.8313 Intermediate Similarity NPD3818 Discontinued
0.8284 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD7808 Phase 3
0.8246 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD7251 Discontinued
0.821 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8208 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD6166 Phase 2
0.8166 Intermediate Similarity NPD6797 Phase 2
0.816 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD8312 Approved
0.8129 Intermediate Similarity NPD8313 Approved
0.811 Intermediate Similarity NPD6234 Discontinued
0.8086 Intermediate Similarity NPD8455 Phase 2
0.805 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD1934 Approved
0.8025 Intermediate Similarity NPD37 Approved
0.8012 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD1653 Approved
0.7988 Intermediate Similarity NPD4967 Phase 2
0.7988 Intermediate Similarity NPD4966 Approved
0.7988 Intermediate Similarity NPD4965 Approved
0.7962 Intermediate Similarity NPD6190 Approved
0.7953 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7941 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.791 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD7240 Approved
0.7798 Intermediate Similarity NPD7199 Phase 2
0.7791 Intermediate Similarity NPD4380 Phase 2
0.7785 Intermediate Similarity NPD8166 Discontinued
0.777 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD5844 Phase 1
0.7725 Intermediate Similarity NPD7075 Discontinued
0.7719 Intermediate Similarity NPD7473 Discontinued
0.7711 Intermediate Similarity NPD3817 Phase 2
0.7697 Intermediate Similarity NPD3027 Phase 3
0.7692 Intermediate Similarity NPD8127 Discontinued
0.7651 Intermediate Similarity NPD2801 Approved
0.7647 Intermediate Similarity NPD6232 Discontinued
0.761 Intermediate Similarity NPD6674 Discontinued
0.7602 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD6233 Phase 2
0.7581 Intermediate Similarity NPD7680 Approved
0.7562 Intermediate Similarity NPD4628 Phase 3
0.756 Intermediate Similarity NPD3882 Suspended
0.7545 Intermediate Similarity NPD7819 Suspended
0.7545 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD2935 Discontinued
0.7532 Intermediate Similarity NPD6798 Discontinued
0.753 Intermediate Similarity NPD7411 Suspended
0.7515 Intermediate Similarity NPD7458 Discontinued
0.75 Intermediate Similarity NPD5402 Approved
0.75 Intermediate Similarity NPD1933 Approved
0.75 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD8151 Discontinued
0.7471 Intermediate Similarity NPD3751 Discontinued
0.7459 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD7768 Phase 2
0.744 Intermediate Similarity NPD1465 Phase 2
0.7436 Intermediate Similarity NPD1613 Approved
0.7436 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD1511 Approved
0.7405 Intermediate Similarity NPD7097 Phase 1
0.7394 Intermediate Similarity NPD5403 Approved
0.7394 Intermediate Similarity NPD7435 Discontinued
0.7391 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD6801 Discontinued
0.7356 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD3787 Discontinued
0.7333 Intermediate Similarity NPD1512 Approved
0.7326 Intermediate Similarity NPD5494 Approved
0.7297 Intermediate Similarity NPD5536 Phase 2
0.7278 Intermediate Similarity NPD230 Phase 1
0.7278 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD447 Suspended
0.7278 Intermediate Similarity NPD6355 Discontinued
0.7273 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5401 Approved
0.7263 Intermediate Similarity NPD7870 Phase 2
0.7263 Intermediate Similarity NPD7871 Phase 2
0.7262 Intermediate Similarity NPD7028 Phase 2
0.7254 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD7874 Approved
0.7249 Intermediate Similarity NPD6823 Phase 2
0.7244 Intermediate Similarity NPD7095 Approved
0.7239 Intermediate Similarity NPD4110 Phase 3
0.7239 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD6782 Approved
0.7234 Intermediate Similarity NPD6780 Approved
0.7234 Intermediate Similarity NPD6779 Approved
0.7234 Intermediate Similarity NPD6777 Approved
0.7234 Intermediate Similarity NPD6781 Approved
0.7234 Intermediate Similarity NPD6776 Approved
0.7234 Intermediate Similarity NPD6778 Approved
0.7226 Intermediate Similarity NPD9494 Approved
0.7222 Intermediate Similarity NPD1549 Phase 2
0.7216 Intermediate Similarity NPD7783 Phase 2
0.7216 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6799 Approved
0.7211 Intermediate Similarity NPD7698 Approved
0.7211 Intermediate Similarity NPD7696 Phase 3
0.7211 Intermediate Similarity NPD7697 Approved
0.7207 Intermediate Similarity NPD7039 Approved
0.7207 Intermediate Similarity NPD7038 Approved
0.7202 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD8150 Discontinued
0.7184 Intermediate Similarity NPD6959 Discontinued
0.7179 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7701 Phase 2
0.7143 Intermediate Similarity NPD7033 Discontinued
0.7143 Intermediate Similarity NPD1510 Phase 2
0.7134 Intermediate Similarity NPD3750 Approved
0.7126 Intermediate Similarity NPD6273 Approved
0.7118 Intermediate Similarity NPD6386 Approved
0.7118 Intermediate Similarity NPD6385 Approved
0.7115 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD8434 Phase 2
0.7101 Intermediate Similarity NPD3455 Phase 2
0.7101 Intermediate Similarity NPD3226 Approved
0.7089 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD3764 Approved
0.7086 Intermediate Similarity NPD1357 Approved
0.7083 Intermediate Similarity NPD8319 Approved
0.7083 Intermediate Similarity NPD8320 Phase 1
0.707 Intermediate Similarity NPD6832 Phase 2
0.7066 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD3705 Approved
0.7059 Intermediate Similarity NPD1091 Approved
0.7059 Intermediate Similarity NPD6599 Discontinued
0.7055 Intermediate Similarity NPD2346 Discontinued
0.7051 Intermediate Similarity NPD2798 Approved
0.7044 Intermediate Similarity NPD4062 Phase 3
0.7041 Intermediate Similarity NPD7801 Approved
0.7037 Intermediate Similarity NPD2799 Discontinued
0.7037 Intermediate Similarity NPD7700 Phase 2
0.7037 Intermediate Similarity NPD7699 Phase 2
0.703 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6653 Approved
0.7011 Intermediate Similarity NPD3749 Approved
0.7007 Intermediate Similarity NPD228 Approved
0.7 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4060 Phase 1
0.7 Intermediate Similarity NPD1240 Approved
0.7 Intermediate Similarity NPD3620 Phase 2
0.6994 Remote Similarity NPD2438 Suspended
0.6994 Remote Similarity NPD2796 Approved
0.6987 Remote Similarity NPD2797 Approved
0.6984 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6981 Remote Similarity NPD3268 Approved
0.6981 Remote Similarity NPD2313 Discontinued
0.698 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6968 Remote Similarity NPD6534 Approved
0.6968 Remote Similarity NPD6535 Approved
0.6964 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6962 Remote Similarity NPD4908 Phase 1
0.6946 Remote Similarity NPD7440 Discontinued
0.6943 Remote Similarity NPD5647 Approved
0.6928 Remote Similarity NPD7003 Approved
0.6923 Remote Similarity NPD7584 Approved
0.6915 Remote Similarity NPD6212 Phase 3
0.6915 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6915 Remote Similarity NPD6213 Phase 3
0.6914 Remote Similarity NPD1607 Approved
0.6913 Remote Similarity NPD5283 Phase 1
0.6909 Remote Similarity NPD970 Clinical (unspecified phase)
0.6903 Remote Similarity NPD1608 Approved
0.6897 Remote Similarity NPD5353 Approved
0.6894 Remote Similarity NPD943 Approved
0.6894 Remote Similarity NPD7966 Clinical (unspecified phase)
0.689 Remote Similarity NPD1551 Phase 2
0.6885 Remote Similarity NPD7549 Discontinued
0.6879 Remote Similarity NPD6844 Discontinued
0.6879 Remote Similarity NPD1203 Approved
0.6875 Remote Similarity NPD919 Approved
0.6875 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6864 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6852 Remote Similarity NPD1899 Clinical (unspecified phase)
0.685 Remote Similarity NPD7930 Approved
0.6846 Remote Similarity NPD7843 Approved
0.6845 Remote Similarity NPD5058 Phase 3
0.6839 Remote Similarity NPD2977 Approved
0.6839 Remote Similarity NPD1535 Discovery
0.6839 Remote Similarity NPD2978 Approved
0.6839 Remote Similarity NPD1547 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data